News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,675 Results
Type
Article (44004)
Company Profile (312)
Press Release (683359)
Multimedia
Podcasts (73)
Webinars (13)
Section
Business (211918)
Career Advice (2097)
Deals (36416)
Drug Delivery (100)
Drug Development (82333)
Employer Resources (176)
FDA (16736)
Job Trends (15321)
News (356246)
Policy (33418)
Tag
Academia (2708)
Accelerated approval (5)
Adcomms (20)
Allergies (89)
Alliances (52475)
ALS (90)
Alzheimer's disease (1403)
Antibody-drug conjugate (ADC) (135)
Approvals (16738)
Artificial intelligence (282)
Autoimmune disease (22)
Automation (16)
Bankruptcy (365)
Best Places to Work (11930)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (221)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (282)
Cancer (2286)
Cardiovascular disease (177)
Career advice (1756)
Career pathing (31)
CAR-T (158)
Cell therapy (438)
Cervical cancer (19)
Clinical research (66806)
Collaboration (869)
Compensation (536)
Complete response letters (19)
COVID-19 (2675)
CRISPR (45)
C-suite (251)
Cystic fibrosis (104)
Data (2226)
Decentralized trials (2)
Denatured (30)
Depression (44)
Diabetes (272)
Diagnostics (6637)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (101)
Drug shortages (27)
Duchenne muscular dystrophy (94)
Earnings (88291)
Editorial (36)
Employer branding (22)
Employer resources (151)
Events (117192)
Executive appointments (748)
FDA (18020)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (779)
Gene editing (113)
Generative AI (26)
Gene therapy (316)
GLP-1 (727)
Government (4517)
Grass and pollen (5)
Guidances (65)
Healthcare (19540)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (30)
Infectious disease (2821)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (100)
Interviews (323)
IPO (16870)
IRA (41)
Job creations (3819)
Job search strategy (1494)
Kidney cancer (10)
Labor market (38)
Layoffs (480)
Leadership (18)
Legal (8128)
Liver cancer (77)
Lung cancer (324)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (311)
MASH (68)
Medical device (14110)
Medtech (14115)
Mergers & acquisitions (20101)
Metabolic disorders (693)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1944)
NextGen: Class of 2025 (6846)
Non-profit (4619)
Now hiring (39)
Obesity (365)
Opinion (217)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (150)
Partnered (21)
Patents (242)
Patient recruitment (111)
Peanut (49)
People (59544)
Pharmaceutical (69)
Pharmacy benefit managers (18)
Phase I (20966)
Phase II (29400)
Phase III (21816)
Pipeline (1203)
Policy (140)
Postmarket research (2583)
Preclinical (9001)
Press Release (71)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (265)
Rare diseases (384)
Real estate (6235)
Recruiting (65)
Regulatory (22865)
Reports (46)
Research institute (2460)
Resumes & cover letters (361)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (71)
Series A (136)
Series B (86)
Service/supplier (15)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (30)
Startups (3841)
State (2)
Stomach cancer (13)
Supply chain (69)
Tariffs (39)
The Weekly (41)
Vaccines (718)
Venture capitalists (42)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Today (173)
Last 7 days (877)
Last 30 days (2708)
Last 365 days (33713)
2025 (10928)
2024 (36220)
2023 (41138)
2022 (52408)
2021 (57005)
2020 (55634)
2019 (48428)
2018 (36456)
2017 (33556)
2016 (33158)
2015 (39379)
2014 (32948)
2013 (27987)
2012 (30247)
2011 (30850)
2010 (28813)
Location
Africa (759)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (40522)
Australia (6745)
California (6234)
Canada (2026)
China (535)
Colorado (272)
Connecticut (285)
Delaware (153)
Europe (88816)
Florida (918)
Georgia (216)
Idaho (60)
Illinois (558)
India (26)
Indiana (315)
Iowa (11)
Japan (164)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (901)
Massachusetts (4707)
Michigan (241)
Minnesota (401)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (25)
Nevada (64)
New Hampshire (69)
New Jersey (1759)
New Mexico (28)
New York (1772)
North Carolina (1014)
North Dakota (9)
Northern California (2705)
Ohio (209)
Oklahoma (15)
Oregon (37)
Pennsylvania (1392)
Puerto Rico (13)
Rhode Island (34)
South America (1154)
South Carolina (22)
South Dakota (1)
Southern California (2338)
Tennessee (103)
Texas (919)
United States (23656)
Utah (187)
Virginia (148)
Washington D.C. (62)
Washington State (569)
West Virginia (3)
Wisconsin (57)
727,675 Results for "haematologic technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology
HUTCHMED Limited announces that results from ESLIM-01, HUTCHMED’s Phase III trial of sovleplenib, in adult patients with primary immune thrombocytopenia in China, were published in The Lancet Haematology.
June 16, 2024
·
9 min read
Press Releases
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
April 16, 2025
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
April 24, 2025
·
2 min read
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Press Releases
FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC.
March 12, 2025
·
3 min read
Press Releases
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma
December 9, 2024
·
9 min read
Press Releases
Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR
April 24, 2025
·
2 min read
Press Releases
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024
November 6, 2024
·
14 min read
Pharm Country
SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference: Updated Date and Time
SELLAS Life Sciences Group, Inc. today announced that the date and time for the presentation of data from the acute myeloid leukemia cohort of patients in the Phase 1 dose-escalation study of SLS009 (formerly GFH009) will be presented in an oral presentation at the 2024 European School of Haematology Acute Leukaemias (ESH) Conference.
February 29, 2024
·
3 min read
1 of 72,768
Next
